Gsk (GSK) Debt to Equity (2016 - 2025)
Historic Debt to Equity for Gsk (GSK) over the last 17 years, with Q1 2025 value amounting to -$12.21.
- Gsk's Debt to Equity changed N/A to -$12.21 in Q1 2025 from the same period last year, while for Mar 2025 it was -$12.21, marking a year-over-year change of. This contributed to the annual value of -$0.94 for FY2024, which is 16955.87% down from last year.
- Gsk's Debt to Equity amounted to -$12.21 in Q1 2025.
- In the past 5 years, Gsk's Debt to Equity ranged from a high of $1.98 in Q4 2022 and a low of -$17.12 during Q1 2021
- Moreover, its 5-year median value for Debt to Equity was -$0.94 (2024), whereas its average is -$3.79.
- In the last 5 years, Gsk's Debt to Equity surged by 2318.96% in 2022 and then crashed by 16955.87% in 2024.
- Gsk's Debt to Equity (Quarter) stood at $1.61 in 2021, then increased by 23.19% to $1.98 in 2022, then tumbled by 31.83% to $1.35 in 2023, then plummeted by 169.56% to -$0.94 in 2024, then tumbled by 1200.51% to -$12.21 in 2025.
- Its Debt to Equity was -$12.21 in Q1 2025, compared to -$0.94 in Q4 2024 and $1.35 in Q4 2023.